Showing results (71-80 of 798) with videos related to
Sort By:
Pageof 80
AIDS (London, England)|July 9, 1999
Highly drug-resistant HIV-1 clinical isolates are cross-resistant to many antiretroviral compounds in current clinical developmentS Palmer, R W Shafer, T C MeriganJournal of Clinical Microbiology|January 1, 1995
Quantitative analysis of syncytium-inducing and non-syncytium-inducing virus in patients infected with human immunodeficiency virus type 1R W Shafer, E Aguiniga, T C MeriganJournal of Neurovirology|June 29, 2000
The association between multiple sclerosis and infection with Epstein-Barr virus and retrovirusS Haahr, M MunchBiomedicine / [Publiee Pour L'A.A.I.C.I.G.]|December 1, 1978
Function of fever in infectious diseaseS Haahr, S MogensenVaccine|January 1, 1992
Liposome-formulated interleukin-2 as an adjuvant of recombinant HSV glycoprotein gD for the treatment of recurrent genital HSV-2 in guinea-pigsR J Ho, R L Burke, T C MeriganThe Journal of Infectious Diseases|March 1, 1997
A novel approach to assessing the drug susceptibility and replication of human immunodeficiency virus type 1 isolatesR M Jellinger, R W Shafer, T C MeriganInfection and Immunity|July 1, 1970
Potentiating Effect of Freund's Adjuvant on Interferon Production by Endotoxin or Poly rI*Poly rCE De Clercq, M R Nuwer, T C MeriganJournal of Virology|December 1, 1973
Structure and infectivity of picornaviral RNA encapsidated by cowpea chlorotic mottle virus proteinD R Black, C J Connell, T C MeriganJournal of Immunology (Baltimore, Md. : 1950)|May 15, 1991
Antiviral activity and dose optimum of recombinant macrophage colony-stimulating factor on herpes simplex genitalis in guinea pigsR J Ho, K T Chong, T C MeriganNature|November 22, 1979
Induction and kinetics of natural killer cells in humans following interferon therapyJ R Huddlestone, T C Merigan, M B OldstonePageof 80